drugset / Trial / NCT02706483
Long Term Safety Study of Plecanatide
NaSingle-groupOpen-labelTreatment
Summary
Multi-center, open-label, long-term safety study
Timeline
- Start
- 2016-01
- Primary completion
- 2017-05
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plecanatide | Peptide | 6 mg | Oral |